 |
 |
> Scotland, Aug 24, 2005 (United Press International via COMTEX) -- Scientists > say a class of drugs known as MAO-B inhibitors may be effective in improving > motor symptoms in people with early Parkinson's disease. > > However, contrary to results from other studies, the researchers found > monoamine oxidase B inhibitors do not appear to slow the disease's > progression. > said mao-b inhibitors are of course 'selegiline' and the new, expensive and much-touted 'rasagiline.' while they claim to be (early) PD panaceas, they're also viewed by the 'life extension' crowd as, well, life extending. alas, no clinical studies for the latter. this may be of interest (from the group that researched and developed both drugs): < http://www.rasagiline.com/metabolite.html > fwiw... :) ariela ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn